Topic Archives: Gilead (GILD)

I’ve gotten a few questions about the latest Technology Profits Confidential (currently $79/yr) tease from Ray Blanco, so although it’s a few weeks old now, and started circulating right in the heat of the first coronavirus downturn in mid-March, I thought I’d take a look today. It is still a current ad, I got it […]

Please indulge Doc Gumshoe while he presents his musings on what’s going on in general in the health-care arena, and in particular, which new drugs are getting the FDA blessing and why, as well as which ones are getting the short straw.   My impressions and conclusions are in some cases only loosely based on […]

This particular bit of news leaves your friend Doc Gumshoe shaking his head in puzzlement.  To wit, in the US it is expected that there will be a substantial shortage of physicians in the upcoming years.   The American Association of Medical Colleges predicts that this shortage may reach about 122,000 physicians by the year […]

Remember Ernie Tremblay’s pitch about a “tiny South Texas lab” that was about to cure every disease using its revolutionary CD19 Cancer Vaccine technology, and ignite a bidding war following its fantastical release of exciting information on June 23? Well, it’s back. Not the stock, that’s still languishing around where it was before Tremblay got […]

[Ed. Note: Dr. KSS writes about medicine and biotech stocks for the Irregulars. He has agreed to our trading restrictions, chooses his own topics, and his words and opinions are his own. You can see all of his old articles and his most recent comments on his Stock Gumshoe page.] “Keep it quiet. (Go slow.) […]

[Dr. KSS writes about medicine and biotech stocks for the Irregulars. He has agreed to our trade restrictions, chooses his own topics, and his words and opinions are his own. You can see all his past articles and recent comments here.] The State of Things is a classy 1982 Wim Wenders film in which a film […]

The folks at Money Map/Money Morning have really taken the “most aggressive advertisers” mantle from the other Agora affiliates of late — we can pretty much count on a new promotional campaign from this publisher becoming the “most asked about” pitch by our readers almost instantly, whether it’s Michael Robinson or Keith Fitz-Gerald or Dr. […]

Everybody’s got to deviate from the norm.  —Rush John Galsworthy wrote that the beginning and endings of human undertakings are untidy. It was never more so than in the early days of HCV, a mere 20 years ago, when a plague first called “non-A non-B hepatitis” began vexing people, progressively scarring their livers and behaving […]

[Ed. Note: Dr. KSS is an MD and PhD who writes about medicine and biotech stocks for the Irregulars. He has agreed to our trading restrictions, and his words and opinions are his own. You can see his past articles and recent comments here.] You’re probably getting it right by now—writing “2016” and not “2015.” […]

[Ed. Note: Dr. KSS writes about medicine and biotech stocks for the Irregulars. He chooses his own topics, and his words and opinions are his own. His bio, past articles, and most recent comments can be seen here. Enjoy!] OUT of the night that covers me, Black as the Pit from pole to pole, I thank […]

[Ed. Note: Dr. KSS writes for the Irregulars about medicine and biotech stocks. He choses his own topics, and his words and opinions are his own. He has agreed to our trading restrictions. Enjoy!] In his smoky baritone, singer Stuart Staples of British midlands musical act Tindersticks is bemoaning how he suspects the woman he […]

“I firmly believe that if the whole materia medica could be sunk to the bottom of the sea, it would be all the better for mankind and all the worse for the fishes.”  — Oliver Wendell Holmes, M. D., Professor of Medicine , Harvard “With all his conscience and one eye askew, So false he […]

[Ed. Note: Dr. KSS writes for the Irregulars about medicine and biotech stocks. He has agreed to our trading restrictions, chooses his own topics, and his words and opinions are his own. Enjoy!] It could be the premise of a tawdry unrated movie that teenage boys sneak glimpses of on Netflix when they’re home alone. […]

[Ed. Note: Dr. KSS writes about medicine and biotech stocks for the Irregulars. He has agreed to our trading restrictions, and his words and opinions are his own. Enjoy!] His tidily rhyming names perhaps destined him for fame. While Jack Kerouac’s work and popularity were before my time, his cultural and literary restlessness assure him […]

[ed note: Dr. KSS is a paid contributor to Stock Gumshoe who writes about biotech stocks for (and discusses them with) the Irregulars. He chooses his own topics, and his words and opinions are his alone. Enjoy!] Greetings fellow Irregulars!  You’ve all been waiting for it….our first-ever annual ceremony in which we look back on […]

[Ed. Note: Dr. KSS writes about medicine and biotech stocks for the Irregulars. His words and opinions are his own, and he has agreed to our trading restrictions.] Want to see something really cool? A hot video clip from a steamy biotech thriller? Watch this. Better yet, when you pull up the video viewing frame, […]

[Ed. Note: Dr. KSS writes about medical topics and biotech stocks for the Irregulars. He has agreed to our trading restrictions, and his thoughts and words are his own. Enjoy!] Here we are, solidly in the postmodern 21st century, “so late in the goddam day,” as one of novelist Martin Amis’s characters says, and what […]

[Ed. Note: Dr. KSS writes about medical topics and biotech stocks for the Irregulars. He has agreed to our trading restrictions, and his thoughts and words are his own. Enjoy!] Any discussion of cholesterol immediately turns Brobdingnagian, such are the extremes in question. Statins, which lower LDL cholesterol, are bombastically the best-selling drugs of all […]

[Ed. Note: Dr. KSS writes about medicine and biotech stocks for the Irregulars. His words and opinions are his own.] In A History of New York, Washington Irving opens chapter VIII thus: ”In which the author and reader…fall into a very grave and instructive discourse.” This may prove to be a more unleavened column than […]

[ed note: We feature the musings of our favorite health and medicine writer, Michael Jorrin, a couple times a month, and we’ve taken the liberty of calling him “Doc Gumshoe” (he’s not a doctor). You’ll find no stock picks in his pieces, but hopefully will get plenty of insight into the medical matters he explains […]

Comments

  • Avatar

    And judging from the 6x normal volume today I'd say RVLGF is his pick. I got an email from him yesterday saying he had ...

  • Travis Johnson, Stock Gumshoe

    This one's looking a little more positive for Frank now that earnings provided some optimism (a "miss" but some positive...

  • Avatar

    Interestingly (I'm a CRA subscriber), now that C has hit $50, despite reaching his stop loss, Curzio has announced he's ...

  • Travis Johnson, Stock Gumshoe

    Frank does talk about stop losses and I get the impression he typically uses them in his newsletters, though I don't kno...

  • Travis Johnson, Stock Gumshoe

    Agree on MLP, covered that one here: https://www.stockgumshoe.com/reviews/curzio-venture-opportunities/whats-curzios-nes...

  • Avatar

    Don't get caught by this "Crypto Intelligence" fraud by Frank Curzio. There was a big multi-months promotion by Frank Cu...

  • Avatar

    Frank Curzio is a snake oil salesman that really needs to look into the mirror and realize he is doing way more harm the...

  • Avatar

    Performance of Curzio's stock picks has been poor to date, hopefully, that will change with time. As mentioned below, th...

  • Travis Johnson, Stock Gumshoe

    Selling is hard, especially when you have to admit that you were wrong in an idea you were really sure about. I haven...

  • Avatar

    Does anybody have any idea which biotech-stock (DNA sequencing) this can be that's being promoted by Frank Curzio? Th...

  • Avatar

    I don't really care that not all the factors are in place, and this is also the reason why the price has been priced ver...

  • Travis Johnson, Stock Gumshoe

    FYI, it's getting hard to find a mining newsletter publisher that's NOT excited about Northern Dynasty these days -- Sta...

  • Avatar

    Yes, I could also sell a small position in not too distant future, since my position is starting to be too big since I g...

  • Avatar

    Lithium X is a regular and favorite paid pump of CEO.ca. Stay away. Having Katusa involved just makes it worse. Kat...

  • Avatar

    Hendrixnuzzles, in an interview with Frank Curzio yesterday, Marin noted there were three ways right now to participate ...

  • Avatar

    I commented on Northern Dynasty (NAK) some time back (and was also trying to figure out Mr Katusa's new gold pick, but I...

  • Avatar

    I am too very cautious at the moment, but have around 15% of my portfolio in silver/gold-mining stocks. Just bought NAK...

  • highlands

    Frank Curzio just did a great interview of Mr. Katusa and UEC. I give Katusa kudos for his passion and commitment to the...

  • Avatar

    I just listened to the Brad Hopman video where he introduced Frank Curzio as just joining their group of Adventure Capi...

  • Travis Johnson, Stock Gumshoe

    Frank Curzio has teased that one a few times as well for his Phase 1 newsletter at Stansberry....

  • Avatar

    Frank Curzio recommended LPI in Oct 2012 @ 19.96. Currently a hold with a "buy up to" price of $22.50...

  • Avatar

    Travis Frank Curzio is at it again. The Marijuana story no one is telling Comment ? Pat...

  • Avatar

    I'm sure many of you got this email, but for those that didn't, Frank Curzio has written an article saying that a "great...

  • Avatar

    I just sat through listening to Frank Curzio tell me about 43 small stocks that could earn up to 30% dividend, and he wo...

  • Avatar

    In mid-May 2013 Frank Curzio specifically mentioned this company in another newsletter (probably one of the free ones fr...

  • Avatar

    The email I saw on this today (Frank Curzio Phase 1 Investor) talked about a small North American driller who somehow go...

  • Avatar

    Actually, the pitchman is Frank Curzio, but what is the stock?...

  • Avatar

    The Next Great Royalty Business By Frank Curzio, editor, Small Stock Specialist He is talking about Altius Minerals...

  • Avatar

    I actually have talked to Frank Curzio, exchanged e-mails, and offered a stock pick to him a several years ago. At th...

  • Avatar

    Frank Curzio recommended the stock last week, which coincided with the price spike...

  • Avatar

    Thanks Travis for all the good work you do. I am new to all this speculative investing on Jr miners but this latest teas...

  • Avatar

    TRAVIS You are the man!!! I just got done reading the tease by Frank Curzio and have been a long time holder of Royal G...

  • Avatar

    Travis, Any information on Frank Curzio new hot stock that's 100% American made "Eagle Diesel" which is dubbed as the ...

  • Travis Johnson, Stock Gumshoe

    Gold Standard Ventures has sure been a nice one this year! That was a Frank Curzio recco for his Phase 1, and it so hap...

  • Avatar

    I heard Frank Curzio talking about trans ocean (RIG). he said they were getting over $600,000 per day drilling. I wonder...

  • Avatar

    looks like Stansberry is pushing this one again. got a newsletter today promising The "gold sands" discovery of a lif...

  • Avatar

    What Gold Sands is Frank Curzio teasing? Apparently the gold is under 1500 meters of water and 5000 miles from New Yor...

  • Avatar

    It depends what kind of investor you are and what you are looking for. Don't expect any of these guys to bet 1000% If...

  • Avatar

    GMXR (GMX resources) is a play on the Williston Basin. It recently fell from about $5 to about $1.70 per share, despite...

  • Avatar

    Once again, good job Travis. I love reading Frank Curzio (I subscribe to his Penny Stock Specialist Newsletter), but I&...

  • Avatar

    Does anyone know what Frank Curzio is touting for his Phase 1 newsletter as the "New Royal Gold"? ...

  • Avatar

    Dr. Eifrig's colleague, Frank Curzio, has a brand new teaser for Phase 1 called the "Next Royal Gold." I...

  • Avatar

    it is on Stanberry's Phase 1 Investor by an analyst named Frank Curzio who has an excelllent track record ...

  • Avatar

    Is there a way to find out if Groote Resources has paid Frank Curzio or Stanberry Associates to promote this stock? ...

  • Avatar

    Frank Curzio hyped Triquint Semiconductor (TQNT), didn't he? I bought at $6.60 per share, held on for about 6 mont...

  • Avatar

    Penny Stock Specialist Frank Curzio does a good job of finding low priced stocks with good prospects. I have had mixe...

  • Avatar

    You were right on your pick of IO which looks like a real winner, especially now that oil prices are rising because of t...

  • Avatar

    MPET was discussed by Frank Curzio in the S&A "Off the Record" back in Nov 2009 issue. Sandstorm is not n...

  • Avatar

    Don't have much track record yet with Frank Curzio, but he appears to be a careful analyst, sincere and dedicated and wi...

  • Avatar

    Isn't Frank Curzio the guy who was in a stock-picking contest a few years back on CNBC with a monkey?.... and lost!...

  • We use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies.

    More Info